Thrombophilia primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
update |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Thrombophilia_medical_therapy| | [[Thrombophilia_medical_therapy|Thromboprophylaxis]] with [[anticoagulation]] may be recommended for primary prevention of acute thrombosis in [[Thrombophilia_medical_therapy|high risk acquired and inherited thrombophilias]]. | ||
==Primary Prevention== | ==Primary Prevention== | ||
Thromboprophylaxis with [[anticoagulation]] may be recommended for primary prevention of acute thrombosis in [[Thrombophilia_medical_therapy|high risk acquired and inherited thrombophilias]].<ref name=?>DeLoughery TG. Hemostasis and Thrombosis: Springer International Publishing; 2014.</ref><ref name="pmid24421360">{{cite journal| author=Cohoon KP, Heit JA| title=Inherited and secondary thrombophilia. | journal=Circulation | year= 2014 | volume= 129 | issue= 2 | pages= 254-7 | pmid=24421360 | doi=10.1161/CIRCULATIONAHA.113.001943 | pmc=3979345 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24421360 }} </ref><ref name="pmid11309638">{{cite journal| author=Seligsohn U, Lubetsky A| title=Genetic susceptibility to venous thrombosis. | journal=N Engl J Med | year= 2001 | volume= 344 | issue= 16 | pages= 1222-31 | pmid=11309638 | doi=10.1056/NEJM200104193441607 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11309638 }} </ref> | |||
*[[Antithrombin]] deficiency | |||
*[[Zygosity|Homozygous or compound heterozygous]] mutations for the underlying thrombophilias | |||
*Multiple thrombophilias | |||
*Family history of [[thrombosis]] at a young age | |||
*Post [[Orthopedic_surgery|orthopedic surgery]] | |||
*Post abdominal or pelvic surgery for gynecologic malignancies | |||
Refer to the [[Thrombophilia_medical_therapy|medical therapy section]] for additional information | |||
==References== | ==References== | ||
Revision as of 19:40, 20 July 2016
|
Thrombophilia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Thrombophilia primary prevention On the Web |
|
American Roentgen Ray Society Images of Thrombophilia primary prevention |
|
Risk calculators and risk factors for Thrombophilia primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Asiri Ediriwickrema, M.D., M.H.S. [2]
Overview
Thromboprophylaxis with anticoagulation may be recommended for primary prevention of acute thrombosis in high risk acquired and inherited thrombophilias.
Primary Prevention
Thromboprophylaxis with anticoagulation may be recommended for primary prevention of acute thrombosis in high risk acquired and inherited thrombophilias.[1][2][3]
- Antithrombin deficiency
- Homozygous or compound heterozygous mutations for the underlying thrombophilias
- Multiple thrombophilias
- Family history of thrombosis at a young age
- Post orthopedic surgery
- Post abdominal or pelvic surgery for gynecologic malignancies
Refer to the medical therapy section for additional information
References
- ↑ DeLoughery TG. Hemostasis and Thrombosis: Springer International Publishing; 2014.
- ↑ Cohoon KP, Heit JA (2014). "Inherited and secondary thrombophilia". Circulation. 129 (2): 254–7. doi:10.1161/CIRCULATIONAHA.113.001943. PMC 3979345. PMID 24421360.
- ↑ Seligsohn U, Lubetsky A (2001). "Genetic susceptibility to venous thrombosis". N Engl J Med. 344 (16): 1222–31. doi:10.1056/NEJM200104193441607. PMID 11309638.